Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yinxian Yang

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 3, 2021
Low dose shikonin and anthracyclines coloaded liposomes induce robust immunogenetic cell death for synergistic chemo-immunotherapyJinbo Li, Shuang Zhou, Jiang Yu, et al.
Colloids and Surfaces. B, Biointerfaces|April 18, 2021
Disulfide bond based cascade reduction-responsive Pt(IV) nanoassemblies for improved anti-tumor efficiency and biosafetyXiao Kuang, Dongxu Chi, Jinbo Li, et al.
Asian Journal of Pharmaceutical Sciences|July 19, 2021
Small changes in the length of diselenide bond-containing linkages exert great influences on the antitumor activity of docetaxel homodimeric prodrug nanoassembliesLingxiao Li, Shiyi Zuo, Fudan Dong, et al.
Small (Weinheim an Der Bergstrasse, Germany)|October 20, 2020
Probing the Superiority of Diselenium Bond on Docetaxel Dimeric Prodrug Nanoassemblies: Small Roles Taking Big ResponsibilitiesShiyi Zuo, Bingjun Sun, Yinxian Yang, et al.
Cell Reports. Medicine|February 22, 2024
Tetrasulfide bond boosts the anti-tumor efficacy of dimeric prodrug nanoassembliesShiyi Zuo, Tian Liu, Lingxiao Li, et al.
Nature Communications|November 1, 2023
An in situ dual-anchoring strategy for enhanced immobilization of PD-L1 to treat autoimmune diseasesShenqiang Wang, Ying Zhang, Yanfang Wang, et al.
Nature Cancer|June 10, 2025
Long-acting IL-2 release from pressure-fused biomineral tablets promotes antitumor immune responseJinpeng Han, Shenqiang Wang, Weifeng Fang, et al.
Nano Letters|January 31, 2023
Structure-Activity Relationship of pH-Sensitive Doxorubicin-Fatty Acid Prodrug Albumin NanoparticlesYinxian Yang, Xiuhong Li, Jiaxuan Song, et al.
Science Advances|November 5, 2020
Trisulfide bond-mediated doxorubicin dimeric prodrug nanoassemblies with high drug loading, high self-assembly stability, and high tumor selectivityYinxian Yang, Bingjun Sun, Shiyi Zuo, et al.
Nature Biomedical Engineering|April 17, 2026
Mammary organoid-based depot for post-surgical chemotherapy and gland regenerationShenqiang Wang, Yinxian Yang, Yanfang Wang, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 3, 2021
Low dose shikonin and anthracyclines coloaded liposomes induce robust immunogenetic cell death for synergistic chemo-immunotherapyJinbo Li, Shuang Zhou, Jiang Yu, et al.
Colloids and Surfaces. B, Biointerfaces|April 18, 2021
Disulfide bond based cascade reduction-responsive Pt(IV) nanoassemblies for improved anti-tumor efficiency and biosafetyXiao Kuang, Dongxu Chi, Jinbo Li, et al.
Asian Journal of Pharmaceutical Sciences|July 19, 2021
Small changes in the length of diselenide bond-containing linkages exert great influences on the antitumor activity of docetaxel homodimeric prodrug nanoassembliesLingxiao Li, Shiyi Zuo, Fudan Dong, et al.
Small (Weinheim an Der Bergstrasse, Germany)|October 20, 2020
Probing the Superiority of Diselenium Bond on Docetaxel Dimeric Prodrug Nanoassemblies: Small Roles Taking Big ResponsibilitiesShiyi Zuo, Bingjun Sun, Yinxian Yang, et al.
Cell Reports. Medicine|February 22, 2024
Tetrasulfide bond boosts the anti-tumor efficacy of dimeric prodrug nanoassembliesShiyi Zuo, Tian Liu, Lingxiao Li, et al.
Nature Communications|November 1, 2023
An in situ dual-anchoring strategy for enhanced immobilization of PD-L1 to treat autoimmune diseasesShenqiang Wang, Ying Zhang, Yanfang Wang, et al.
Nature Cancer|June 10, 2025
Long-acting IL-2 release from pressure-fused biomineral tablets promotes antitumor immune responseJinpeng Han, Shenqiang Wang, Weifeng Fang, et al.
Nano Letters|January 31, 2023
Structure-Activity Relationship of pH-Sensitive Doxorubicin-Fatty Acid Prodrug Albumin NanoparticlesYinxian Yang, Xiuhong Li, Jiaxuan Song, et al.
Science Advances|November 5, 2020
Trisulfide bond-mediated doxorubicin dimeric prodrug nanoassemblies with high drug loading, high self-assembly stability, and high tumor selectivityYinxian Yang, Bingjun Sun, Shiyi Zuo, et al.
Nature Biomedical Engineering|April 17, 2026
Mammary organoid-based depot for post-surgical chemotherapy and gland regenerationShenqiang Wang, Yinxian Yang, Yanfang Wang, et al.
Pageof 3